{"id":{"repo_id":"purdue-thes","oai_identifier":"oai:docs.lib.purdue.edu:open_access_dissertations-2511"},"canonical_url":"https://search.dev.ndltd.org/etd/purdue-thes/oai:docs.lib.purdue.edu:open_access_dissertations-2511","repository":{"repo_id":"purdue-thes","name":"Purdue University","base_url":"https://docs.lib.purdue.edu/do/oai/"},"display":{"title":"ACID-BASE REACTIONS IN DIFFERENT SOLID-STATE FORMS","abstract":"Most drug substances are reported to be either weak acids or weak bases. Hence, acid-base reactions are commonly observed in pharmaceutical systems with samples including salts, amorphous solid dispersions, and in formulated products. Salt formation of active pharmaceutical ingredients (APIs) is widely recognized as one of the most commonly used approaches to modify the solubility and dissolution rate. Formulating poorly water-soluble weak acids or weak bases into salts can not only increase bioavailability, but also improve the stability and manufacturability of APIs by changing their solid-state properties. However, from a formulation perspective, acid-base reactions might occur between APIs and ionizable excipients, which would induce deleterious form conversions or chemical degradation of the APIs during storage or manufacturing. Therefore, understanding the fundamentals of acid-base reactions is critical to design a robust formulation and to avoid drug-excipients incompatibility issues in multicomponent pharmaceutical products.","abstract_html":"Most drug substances are reported to be either weak acids or weak bases. Hence, acid-base reactions are commonly observed in pharmaceutical systems with samples including salts, amorphous solid dispersions, and in formulated products. Salt formation of active pharmaceutical ingredients (APIs) is widely recognized as one of the most commonly used approaches to modify the solubility and dissolution rate. Formulating poorly water-soluble weak acids or weak bases into salts can not only increase bioavailability, but also improve the stability and manufacturability of APIs by changing their solid-state properties. However, from a formulation perspective, acid-base reactions might occur between APIs and ionizable excipients, which would induce deleterious form conversions or chemical degradation of the APIs during storage or manufacturing. Therefore, understanding the fundamentals of acid-base reactions is critical to design a robust formulation and to avoid drug-excipients incompatibility issues in multicomponent pharmaceutical products.","abstract_has_math":false,"creators":["Nie, Haichen"],"institution":null,"degree_name":"Doctor of Philosophy (PhD)","degree_level":"Dissertation","degree_discipline":"Industrial and Physical Pharmacy","degree_department":null,"school":null,"contributors":["Stephen R. Byrn","Lynne S. Taylor","Rodolfo Pinal","Gregory T. Knipp","Patrick J. Marsac"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2016,"date_issued":"2016-01-01T08:00:00Z","date_published":"2016-01-01T08:00:00Z","updated_at":"2026-07-24T03:54:31Z","subjects":["Amorphous Solid Dispersion","Drug-excipient compatibility","Drug-polymer interactions","Salt disproportionation","Salt formation"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://docs.lib.purdue.edu/open_access_dissertations/1295","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Stephen R. Byrn","Lynne S. Taylor","Rodolfo Pinal","Gregory T. Knipp","Patrick J. Marsac"]},{"key":"dc:creator","label":"Author","values":["Nie, Haichen"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"thesis:degree_discipline","label":"Discipline","values":["Industrial and Physical Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Amorphous Solid Dispersion","Drug-excipient compatibility","Drug-polymer interactions","Salt disproportionation","Salt formation"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://docs.lib.purdue.edu/open_access_dissertations/1295"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Most drug substances are reported to be either weak acids or weak bases. Hence, acid-base reactions are commonly observed in pharmaceutical systems with samples including salts, amorphous solid dispersions, and in formulated products. Salt formation of active pharmaceutical ingredients (APIs) is widely recognized as one of the most commonly used approaches to modify the solubility and dissolution rate. Formulating poorly water-soluble weak acids or weak bases into salts can not only increase bioavailability, but also improve the stability and manufacturability of APIs by changing their solid-state properties. However, from a formulation perspective, acid-base reactions might occur between APIs and ionizable excipients, which would induce deleterious form conversions or chemical degradation of the APIs during storage or manufacturing. Therefore, understanding the fundamentals of acid-base reactions is critical to design a robust formulation and to avoid drug-excipients incompatibility issues in multicomponent pharmaceutical products."]},{"key":"dc:title","label":"Title","values":["ACID-BASE REACTIONS IN DIFFERENT SOLID-STATE FORMS"]}]}],"canonical_facts":{"dc:contributor":["Stephen R. Byrn","Lynne S. Taylor","Rodolfo Pinal","Gregory T. Knipp","Patrick J. Marsac"],"dc:creator":["Nie, Haichen"],"dc:description.abstract":["Most drug substances are reported to be either weak acids or weak bases. Hence, acid-base reactions are commonly observed in pharmaceutical systems with samples including salts, amorphous solid dispersions, and in formulated products. Salt formation of active pharmaceutical ingredients (APIs) is widely recognized as one of the most commonly used approaches to modify the solubility and dissolution rate. Formulating poorly water-soluble weak acids or weak bases into salts can not only increase bioavailability, but also improve the stability and manufacturability of APIs by changing their solid-state properties. However, from a formulation perspective, acid-base reactions might occur between APIs and ionizable excipients, which would induce deleterious form conversions or chemical degradation of the APIs during storage or manufacturing. Therefore, understanding the fundamentals of acid-base reactions is critical to design a robust formulation and to avoid drug-excipients incompatibility issues in multicomponent pharmaceutical products."],"dc:identifier":["https://docs.lib.purdue.edu/open_access_dissertations/1295"],"dc:subject":["Amorphous Solid Dispersion","Drug-excipient compatibility","Drug-polymer interactions","Salt disproportionation","Salt formation"],"dc:title":["ACID-BASE REACTIONS IN DIFFERENT SOLID-STATE FORMS"],"thesis:degree_discipline":["Industrial and Physical Pharmacy"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Doctor of Philosophy (PhD)"]},"updated_at":"2026-07-24T03:54:31Z"}